CoChat

Efficacy and Safety of Intravenous Mesenchymal Stem Cells for Ischemic Stroke

Chung, Jong-Won, Chang, Won Hyuk, Bang, Oh Young, Moon, Gyeong Joon, Kim, Suk Jae, Kim, Soo-Kyoung, Lee, Jin Soo, Sohn, Sung-Il, Kim, Yun-Hee, for the STARTING-2 Collaborators · 2021 · Neurology
Cited by 200

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

ObjectiveTo test whether autologous modified mesenchymal stem cells (MSCs) improve recovery in patients with chronic major stroke. MethodsIn this prospective, open-label, randomized controlled trial with blinded outcome evaluation, patients with severe middle cerebral artery territory infarct within 90 days of symptom onset were assigned, in a 2:1 ratio, to receive preconditioned autologous MSC injections (MSC group) or standard treatment alone (control group). The primary outcome was the score on the modified Rankin Scale (mRS) at 3 months. The secondary outcome was to further demonstrate motor recovery. ResultsA total of 39 and 15 patients were included in the MSC and control groups, respectively, for the final intention-to-treat analysis. Mean age of patients was 68 (range 28–83) years, and mean interval between stroke onset to randomization was 20.2 (range 5–89) days. Baseline characteristics were not different between groups. There was no significant difference between the groups in the mRS score shift at 3 months (p = 0.732). However, secondary analyses showed significant improvements in lower extremity motor function in the MSC group compared to the control group (change in the leg score of the Motricity Index, p = 0.023), which was notable among patients with low predicted recovery potential. There were no serious treatment-related adverse events. ConclusionsIV application of preconditioned, autologous MSCs with autologous serum was feasible and safe in patients with chronic major stroke. MSC treatment was not associated with improvements in the 3-month mRS score, but we did observe leg motor improvement in detailed functional analyses. Classification of EvidenceThis study provides Class III evidence that autologous MSCs do not improve 90-day outcomes in patients with chronic stroke.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1212/wnl.0000000000011440

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 35

  1. 10.1016/S1474-4422(02)00040-6 · DOI · Paper page
  2. 10.1002/stem.430 · DOI · Paper page
  3. 10.3727/096368908786991551 · DOI
  4. 10.1161/STROKEAHA.109.568881 · DOI · Paper page
  5. 10.1093/brain/awr063 · DOI · Paper page
  6. 10.3727/096368916X690430 · DOI
  7. 10.1007/s12975-017-0538-2 · DOI
  8. 10.1177/0963689718755404 · DOI
  9. 10.1186/1745-6215-14-317 · DOI · Paper page
  10. 10.1002/ana.20501 · DOI · Paper page
  11. 10.1159/000115178 · DOI · Paper page
  12. 10.1016/j.apmr.2007.06.764 · DOI · Paper page
  13. 10.1002/ana.24472 · DOI · Paper page
  14. Hawe RL, Scott SH, Dukelow SP. Taking proportional out of stroke recovery. Stroke Epub 2018 Dec 7.
  15. 10.1093/brain/aws146 · DOI · Paper page
  16. 10.1002/acn3.488 · DOI · Paper page
  17. 10.1310/tsr18s01-599 · DOI · Paper page
  18. 10.1179/1945511915Y.0000000003 · DOI
  19. 10.1016/j.nicl.2013.04.002 · DOI
  20. 10.3109/03790798909166398 · DOI
  21. 10.1161/STROKEAHA.108.533208 · doi:10.1161/strokeaha.108.533208
  22. 10.1161/STROKEAHA.110.601914 · DOI · Paper page
  23. 10.1001/jama.2016.13647 · DOI · Paper page
  24. 10.1093/jnen/63.1.84 · DOI · Paper page
  25. 10.1161/STROKEAHA.112.679605 · DOI
  26. 10.3727/096368913X674666 · DOI
  27. 10.1016/S1474-4422(17)30046-7 · DOI · Paper page
  28. 10.1089/scd.2016.0268 · DOI
  29. 10.1038/sj.jcbfm.9600217 · DOI · Paper page
  30. 10.1089/scd.2012.0037 · DOI
  31. 10.1002/sctm.18-0236 · DOI
  32. 10.1016/j.ymthe.2004.02.012 · DOI · Paper page
  33. 10.1089/10430340260201699 · DOI · Paper page
  34. 10.1016/j.jcyt.2013.05.020 · DOI
  35. 10.1161/01.STR.0000141680.49960.d7 · DOI · Paper page

Cited by

See all 200

Metadata

Authors
Chung, J.-W., Chang, W. H., Bang, O. Y., Moon, G. J., Kim, S. J., Kim, S.-K., Lee, J. S., Sohn, S.-I., Kim, Y.-H., & Collaborators, F. T. S.-2.
Venue
Neurology
Published
2021-02-16
Volume
96
Issue
7
Pages
e1012-e1023
ISSN
  • 0028-3878 (ISSN-L)
  • 1526-632X
OpenAlex
W3125304137
Cited by
200
References
4
FWCI
16.79
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Efficacy and Safety of Intravenous Mesenchymal Stem Cells for Ischemic Stroke. https://app.cochat.ai/papers/10.1212/wnl.0000000000011440
The paper
Chung, J.-W., Chang, W. H., Bang, O. Y., Moon, G. J., Kim, S. J., Kim, S.-K., Lee, J. S., Sohn, S.-I., Kim, Y.-H., & Collaborators, F. T. S.-2. (2021). Efficacy and Safety of Intravenous Mesenchymal Stem Cells for Ischemic Stroke. Neurology. https://doi.org/10.1212/wnl.0000000000011440

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.